Plasma genotyping of patients in the eXalt2 trial: ensartinib (X-396) in ALK non-small cell lung cancer (NSCLC) - Genotyping - Document - PDFSEARCH.IO

First Page	Meta Content
	Plasma genotyping of patients in the eXalt2 trial: + ensartinib (X-396) in ALK+ non-small cell lung cancer (NSCLC) Add to Reading List Document Date: 2017-01-03 23:04:13 Open Document File Size: 519,41 KB Share Result on Facebook

Plasma genotyping of patients in the eXalt2 trial: + ensartinib (X-396) in ALK+ non-small cell lung cancer (NSCLC)Add to Reading List